Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
Vale SA
VALE
KB Home
KBH
Apple
AAPL
US Stock MarketDetailed Quotes
TMDX TransMedics
- 72.180
- +0.960+1.35%
Close Feb 14 16:00 ET
- 72.190
- +0.010+0.01%
Post 20:01 ET
2.42BMarket Cap77.61P/E (TTM)
74.215High71.990Low1.01MVolume72.870Open71.220Pre Close74.06MTurnover3.14%Turnover RatioLossP/E (Static)33.56MShares177.37052wk High11.54P/B2.33BFloat Cap55.00052wk Low--Dividend TTM32.33MShs Float177.370Historical High--Div YieldTTM3.12%Amplitude10.000Historical Low72.998Avg Price1Lot Size
About TransMedics Company
TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.
Company Profile
SymbolTMDX
Company NameTransMedics
Listing DateMay 2, 2019
Issue Price16.00
Founded1998
CEODr. Waleed Hassanein, M.D.
MarketNASDAQ
Employees584
Fiscal Year Ends12-31
Address200 Minuteman Road,Suite 302
CityAndover
ProvinceMassachusetts
CountryUnited States of America
Zip Code01810
Phone1-978-552-0900
Websitehttp://www.transmedics.com
Company Executives
- Name
- Position
- Salary
- Dr. Waleed Hassanein, M.D.
- President, Chief Executive Officer and Director
- 6.76M
- Gerardo Hernandez
- Chief Financial Officer and Treasurer
- --
- Dr. Tamer Khayal, M.D.
- Chief Commercial Officer
- 2.63M
- Nick Corcoran
- Senior Vice President, Supply Chain and Operations
- 2.52M
- Anil P. Ranganath
- Senior Vice President, General Counsel and Corporate Secretary
- 2.19M
- James R. Tobin
- Chairman of the Board
- 262.32K
- Stephanie Lovell
- Independent Director
- 219.79K
- Merilee Raines
- Independent Director
- 238.62K
- Dr. David Weill, M.D.
- Independent Director
- 222.78K
- Thomas J. Gunderson
- Independent Director
- 237.74K
- Edwin M. Kania, Jr.
- Independent Director
- 220.28K
- Edward M. Basile
- Independent Director
- 232.26K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.